论文部分内容阅读
目的探讨联合应用平阳霉素及地塞米松治疗婴幼儿血管瘤的效果及不良反应。方法选择56例婴幼儿血管瘤患者为研究对象,所有瘤体均位于颌面部,于瘤内注射平阳霉素及地塞米松,长期随访,观察疗效。结果本文56例瘤体共61个,治愈率为80.33%,显效率为11.48%,有效率为8.2%,总有效率为100.0%。其中6例注射后出现溃疡,13例出现色素沉着,9例出现低热。结论联合应用地塞米松及平阳霉素对颌面部血管瘤的婴幼儿患者进行治疗,能够将颜面重要器官功能及解剖形态最大限度保留,患儿痛苦小,治愈率高,不良反应少,操作简单。
Objective To investigate the efficacy and adverse reactions of combined use of pingyangmycin and dexamethasone in infantile hemangiomas. Methods 56 cases of infantile hemangioma were selected as the research object. All the tumors were located in the maxillofacial region. The tumor was injected with bleomycin and dexamethasone for a long time to observe the curative effect. Results In this paper, there were 61 tumors with a total cure rate of 80.33%. The effective rate was 11.48%, the effective rate was 8.2% and the total effective rate was 100.0%. Of these, 6 developed ulceration after injection, 13 developed pigmentation, and 9 developed fever. Conclusion The combination of dexamethasone and pingyangmycin in the treatment of maxillofacial hemangiomas in infants and young children can preserve the function and anatomy of facial vital organs to the maximum extent with little pain, high cure rate and few adverse reactions. Operation simple.